Users Online: 644
Home Print this page Email this page
Home About us Editorial board Search Browse articles Submit article Ahead of Print Instructions Subscribe Contacts Special issues Login 

    Article Cited by others


Case report of the bronchioloalveolar carcinoma

Emami Mohammad, Kalantari Elham

Year : 2015| Volume: 4| Issue : 1 | Page no: 30-30

   This article has been cited by
1 Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms
Pawel Petryszyn,Aleksandra Staniak,Agnieszka Wolosianska,Pawel Ekk-Cierniakowski
European Journal of Gastroenterology & Hepatology. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
Eamonn M. M. Quigley
Therapeutic Advances in Gastroenterology. 2016; 9(2): 199
[Pubmed]  [Google Scholar] [DOI]
3 Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
Hossam M. Elsaadany,Mohammed F. Almaghraby,Awatif A. Edrees,Yasser M. Elsherbiny,Roobina K. Kumar
The Egyptian Journal of Internal Medicine. 2016; 28(1): 21
[Pubmed]  [Google Scholar] [DOI]
4 Recent advances in the diagnosis of irritable bowel syndrome
Magdy El-Salhy
Expert Review of Gastroenterology & Hepatology. 2015; 9(9): 1161
[Pubmed]  [Google Scholar] [DOI]


Read this article